An injectable contraception used by women in some countries has been linked to an increased risk of a type of brain tumour. The study, published in the British Medical Journal (BMJ), found people ...

Please provide your email address to receive an email when new articles are posted on . Prolonged use of medroxyprogesterone acetate injection associated with a 5.6-fold increased risk. Use of ...

The hormonal treatments cyproterone acetate and medroxyprogesterone acetate are the most effective at reducing hot flushes, a common side-effect in men being treated with hormone therapy for prostate ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc., the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation (CIFF) today announced a multi-year extension of their collaboration to ...

Depot medroxyprogesterone acetate use was tied to higher meningioma risk in a large U.S. study. Other contraceptives, including IUDs and combined oral pills, showed no increased meningioma risk.

Prolonged use of certain progestogen hormone drugs is associated with an increased risk of developing a type of brain tumour known as an intracranial meningioma, finds a study from France published by ...

The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns. Depo-Provera ...

Teva Pharmaceutical Industries Ltd., TEVA announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) 150 ...